Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Drug-Coated Stents May Get ICD-9 Code In Time For Cypher Approval In 2003

This article was originally published in The Gray Sheet

Executive Summary

Drug-eluting coronary stents are likely to receive a unique ICD-9-CM code in time for the first FDA approval of the devices, expected by Johnson & Johnson/Cordis in 2003

You may also be interested in...



CMS Drug-Eluting Stent Payment Window Open Until Sept. 1

A separate ICD-9 code for drug-eluting stents will not be included in the Medicare FY 2003 inpatient payment rule unless FDA approves J&J/Cordis' Cypher before Sept. 1, according to the Centers for Medicare & Medicaid Services

CMS Drug-Eluting Stent Payment Window Open Until Sept. 1

A separate ICD-9 code for drug-eluting stents will not be included in the Medicare FY 2003 inpatient payment rule unless FDA approves J&J/Cordis' Cypher before Sept. 1, according to the Centers for Medicare & Medicaid Services

Concurrent CMS/FDA Review Is “The Real Issue,” Not OPPS Data – Scully

AdvaMed is hoping to assist the Centers for Medicare & Medicaid Services as the agency devises its 2003 outpatient prospective payment system (OPPS) update, but will be forced to do so without the benefit of analyzing data from years past

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015641

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel